By Dani Kass ( December 1, 2020, 11:01 PM EST) -- A Teva unit infringed five valid Tris Pharma Inc. patents when applying to sell a generic version of the ADHD treatment Quillivant XR, a Delaware federal judge has ruled in an about-face from the court's first decision in the litigation. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.